Thermolabile drugs: pharmacist intevention as a guarantee of cold chain maintenance
Objective: To determine whether pharmacist is able to guaranteecold chain maintenance of thermolabile drugs during transportusing the available information in the reception processand to compare these results with those obtained in a subsequentintervention phase, in which the manufacturing laborator...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2014-05-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_df4c8823e40e4d1e8072cbb13f4458c9 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a I. Ricote-Lobera |e author |
| 700 | 1 | 0 | |a B. Santos-Mena |e author |
| 700 | 1 | 0 | |a S. Fraile-Gil |e author |
| 700 | 1 | 0 | |a B. Ortiz-Martín |e author |
| 700 | 1 | 0 | |a F. J. Hidalgo-Correas |e author |
| 700 | 1 | 0 | |a B. García-Díaz |e author |
| 245 | 0 | 0 | |a Thermolabile drugs: pharmacist intevention as a guarantee of cold chain maintenance |
| 260 | |b Elsevier, |c 2014-05-01T00:00:00Z. | ||
| 500 | |a 10.7399/fh.2014.38.3.1123 | ||
| 500 | |a 1130-6343 | ||
| 500 | |a 2171-8695 | ||
| 520 | |a Objective: To determine whether pharmacist is able to guaranteecold chain maintenance of thermolabile drugs during transportusing the available information in the reception processand to compare these results with those obtained in a subsequentintervention phase, in which the manufacturing laboratorieswere contacted. Methods: Intervention study, prospective and comparative"before-after". It was analyzed the storage conditions duringtransport of all thermolabile drugs received in a 400-bed hospitalfor 3 months, excluding those from clinical trials. Results: The intervention allowed to ensure cold chain maintenancein 76,5% (n = 488) of received drugs, representing anincrease of 41,8% (IC 95% 36,7-46,6%; p < 0,001) comparedwith the percentage obtained before the intervention. Conclusions: The pharmacist isn't able to ensure the cold chainmaintenance of received thermolabile drugs without temperaturemonitoring device (64,6%). Reports requested from laboratoriesallowed to increase significantly that percentage. | ||
| 546 | |a EN | ||
| 546 | |a ES | ||
| 690 | |a Cold chain | ||
| 690 | |a Thermolabile drugs; | ||
| 690 | |a Drug stability | ||
| 690 | |a Drug distribution | ||
| 690 | |a Refrigeration | ||
| 690 | |a Pharmacist intervention | ||
| 690 | |a Protocol | ||
| 690 | |a ; Quality | ||
| 690 | |a Pharmacy and materia medica | ||
| 690 | |a RS1-441 | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Farmacia Hospitalaria, Vol 38, Iss 3, Pp 211-215 (2014) | |
| 787 | 0 | |n http://www.aulamedica.es/fh/pdf/1123.pdf | |
| 787 | 0 | |n https://doaj.org/toc/1130-6343 | |
| 787 | 0 | |n https://doaj.org/toc/2171-8695 | |
| 856 | 4 | 1 | |u https://doaj.org/article/df4c8823e40e4d1e8072cbb13f4458c9 |z Connect to this object online. |